Guidelines for the Diagnosis and Management of Herb-Induced Liver Injury
- 78 Downloads
Herb-induced liver injury (HILI) is a type of adverse drug reactions related to using Chinese medicine (CM) or herbal medicine (HM), and is now a growing segment of drug-induced liver injury (DILI) worldwide. Owing to the complicated compositions and miscellaneous risk factors associated with the clinical usage of CM or HM, it is more challenging to diagnose and manage HILI than DILI. In the present guideline issued by the China Association of Chinese Medicine (CACM), the authors present an evidence chain-based workflow with 9 structured judgment criteria for diagnosing HILI. The 3 diagnostic ending points—suspected diagnosis, clinical diagnosis, and confifi rmed diagnosis—could be reached according to the length of the evidence chain acquired in the structured diagnostic workflfl ow. Either identifying the species of CM or HM or excluding adulterations and toxin contaminants was strongly recommended to improve the level of evidence for a clinical diagnosis of HILI. In addition, the authors report that the improper use of CM, which violates the general law of CM theory, is one of the most important factors that contributes to HILI and should be avoided. By contrast, based on syndrome differentiation, some CM can also be used to treat HILI if used in accordance with the general law of CM theory. Therefore, 9 recommendations are put forward in this guideline.
Keywordsherb-induced liver injury diagnosis treatment management Chinese medicine guideline
Unable to display preview. Download preview PDF.
The authors thank to LI Li, ZHANG Tao, LIU Cheng-hai, SUN Ke-wei, YANG Hua-sheng, and GUO Yu-ming for their drafting of guidelines. MA An-lin, LU Bing-jiu, LI Bao-sen, XU Chun-jun, GOU Chun-yan, MAO De-wen, SUN Feng-xia, LI Feng-yi, WANG Guiqiang, SONG Hai-bo, LIU Hua-bao, WANG Hua-ning, GUO Jianchun, HU Jian-hua, JIA Jian-wei, HE Jin-song, ZHANG Jun-fu, ZHANG Jun-hua, LI Jun, LIU Jin-min, WANG Li-fu, GONG Man, CHE Nian-cong, ZHANG Ping, GUO Peng, LI Qin, WANG Rongbing, WANG Rui-lin, LUO Sheng-qiang, YAO Shu-kun, ZHANG Wei, ZHAO Wen-xia, WANG Xian-bo, SUN Xiao-bo, LI Xiao-dong, WANG Xiao-jun, CHI Xiao-ling, CHEN Xiao-rong, HU Xiao-yu, GAO Xiu-mei, SUN Xue-hua, ZHAO Yan-ling, YIN Yan-yao, LI Yong, LI Yong-gang, GAO Yue, GAO Yue-qiu, ZOU Zheng-sheng, CHEN Ke-ji, ZHANG Bo-li, WANG Yong-yan, ZHOU Hong-hao, LIU Chang-xiao, LI Lianda, QIAN Ying, WANG Cheng-bai, WANG Ling-tai, and WENG Weiliang were acknowledged for their suggestions and consultation. The authors thank to HU Huang-wan-yin for her assistance in language translation. The authors also thank to Neil Kaplowitz for his review and suggestion to the manuscript.
- 8.Group of Hepatobiliary Disease of Digestive Disease Branch of Chinese Medical Association, Xu JM. A multicenter survey on hospital inpatients with drug-induced acute liver injury in China. Chin J Dig (Chin) 2007;27:439–442.Google Scholar
- 11.Chen YF, Cai HD. Investigation of herb induced liver injury. Adver Drug React J 1999;27–31.Google Scholar
- 12.Wu XN, You H, Jia JD. Clinical features of drug-induced liver injury: a review of Chinese literature 2003-2007. Chin Hepat (Chin) 2008;13:463–466.Google Scholar
- 14.Zhu Y, Li YG, Wang Y, Wang LP, Wang JB, Wang RL, et al. Clinical analysis of 595 cases of herb induced liver injury. Chin J Integr Med 2016;36:38–42.Google Scholar
- 16.Deng WL. Toxicological studies of Tripterigyum willfordii. Pharmacol Clin Chin Mate Med (Chin) 2001;17:42–47.Google Scholar
- 17.Xiao WL, Motley TJ, Unachukwu UJ, Sanlau CB, Jiang B, Hong F, et al. Chemical and genetic assessment of variability in commercial Radix Astragali (Astragalus spp) by ion trap LCMS and nuclear ribosomal DNA barcoding sequence analyses. J Agric Food Chem 2011;59:1548–1556.CrossRefPubMedPubMedCentralGoogle Scholar
- 19.Teschke R. Traditional Chinese Medicine induced liver injury. J Clin Translat Hepatol 2014;2:80–94.Google Scholar
- 20.Tu C, Jiang BQ, Zhao YL, Li CY, Li N, Li XF, et al. Comparison of processed and crude Polygoni Multiflori Radix induced rat liver injury and screening for sensitive indicators. Chin J Chin Mater Med (Chin) 2015;40:654–660.Google Scholar
- 21.Hu YY, Huang F. Chinese herb and drug-induced liver injury. Chin J Hepatol (Chin) 2012;20:173–175.Google Scholar
- 25.Drug-induced Liver Disease Study Group, Chinese. Guidelines for the management of drug-induced liver injury. J Clin Hepatol (Chin) 2015;31:1752–1769.Google Scholar
- 27.Drug-induced Liver Disease Study Group, Chinese. Guideline interpretation on diagnosis and treatment of drug-induced liver injury. Shanghai: Shanghai Science and Technology Press, 2015:1–6.Google Scholar
- 28.World Federation of Chinese Medicine Societies. The International Standard Chinese-English Basic Nomenclature of Chinese Medicine (SCM0002-2007). Beijing: People’s Medical Publishing House; 2007.Google Scholar
- 34.Wang JB, LI CY, Zhu Y, Song HB, Bai ZF, Xiao XH. Integrated evidence chain-based identifi cation of Chinese herbal medicineinduced hepatotoxicity and rational usage: exemplification by Polygonum Multiflorum (He shou wu). Chin Sci Bull 2016;61:971–980.Google Scholar
- 37.Liu FF, Duan XZ, Zang H. Comparative analysis of clinical and hepatic pathologic features in patients with acute drug-induced liver injury caused by traditional Chinese herbs and chemical medicines. J Clin Hepat 2013;16:317–319.Google Scholar
- 38.Efficacy and safety of glucocorticosteroid treatment in the patients with chronic recurrent DILI. NCT02651350.Google Scholar